What is it about?

This paper considers the role of heterogeneity in women's adherence to cancer screening when designing an optimal breast cancer screening strategy.

Featured Image

Why is it important?

Breast cancer is the most common non-skin cancer among women and low adherence is the primary reason for suboptimal clinical benefit from cancer screening. This is a timely study that considers how to consider imperfect adherence in cancer screening guideline design.

Read the Original

This page is a summary of: Heterogeneity in Women’s Adherence and Its Role in Optimal Breast Cancer Screening Policies, Management Science, May 2016, INFORMS,
DOI: 10.1287/mnsc.2015.2180.
You can read the full text:

Read

Contributors

The following have contributed to this page